Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Current gross examination and reporting patterns of post-neoadjuvant chemotherapy
cystectomy specimens: Is it time for a standardized approach?
Am J Clin Pathol. 2024;161:483-489.
PubMed
Abstract available
Correlation between Ki-67 or Profilin-1 Expression Levels, Clinicopathological
Characteristics and Postoperative Prognosis in Patients with Bladder Cancer.
Ann Ital Chir. 2024;95:246-252.
PubMed
Abstract available
The co-expression of antigen targets as a rationale for ADC combination in
urothelial cancer.
Ann Oncol. 2024;35:477-478.
PubMed
ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral
Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective
Observational Study.
Ann Surg Oncol. 2024 Apr 26. doi: 10.1245/s10434-024-15340.
PubMed
Muscle-Invasive Bladder Cancer With Hydronephrosis Exhibits a High Frequency of
Mutations in Fibroblast Growth Factor Receptor 3 Gene.
Anticancer Res. 2024;44:1947-1954.
PubMed
Abstract available
Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of
Bladder Cancer.
Anticancer Res. 2024;44:1837-1844.
PubMed
Abstract available
Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in
Patients With Metastatic Urothelial Carcinoma.
Anticancer Res. 2024;44:2117-2123.
PubMed
Abstract available
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-gamma-induced
Apoptosis in Urothelial Cancer.
Anticancer Res. 2024;44:1925-1930.
PubMed
Abstract available
Taurine Rescues Cancer-induced Atrophy in Human Skeletal Muscle Cells via
Ameliorating the Inflammatory Tumor Microenvironment.
Anticancer Res. 2024;44:1963-1971.
PubMed
Abstract available
Metabolomics for the diagnosis of bladder cancer: A systematic review.
Asian J Urol. 2024;11:221-241.
PubMed
Abstract available
Circulating Tumour DNA and Its Prognostic Role in Management of Muscle Invasive
Bladder Cancer: A Narrative Review of the Literature.
Biomedicines. 2024;12:921.
PubMed
Abstract available
Racial disparities in stage at bladder cancer diagnosis in the US Veterans
Affairs healthcare system.
BJU Int. 2024 Apr 29. doi: 10.1111/bju.16380.
PubMed
Abstract available
Predicting preoperative muscle invasion status for bladder cancer using computed
tomography-based radiomics nomogram.
BMC Med Imaging. 2024;24:98.
PubMed
Abstract available
Unrecognised paraganglioma of the urinary bladder precipitating hypertensive
crisis.
BMJ Case Rep. 2024;17:e259283.
PubMed
Abstract available
Anastomosing haemangioma of adrenal gland: an unusual vascular tumour.
BMJ Case Rep. 2024;17:e259092.
PubMed
Abstract available
Radiotherapy and Anrotinib in Malignant Glomus Tumor of the Bladder: A Case
Report and Literature Review.
Cancer Biother Radiopharm. 2024;39:318-321.
PubMed
Abstract available
Metabolic reprogramming of tumor-associated macrophages using glutamine
antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder
cancer tumors.
Cancer Immunol Res. 2024 May 3. doi: 10.1158/2326-6066.CIR-23-1105.
PubMed
Abstract available
tRNA-Derived Fragments as Biomarkers in Bladder Cancer.
Cancers (Basel). 2024;16:1588.
PubMed
Abstract available
Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive
Bladder Cancer.
Cancers (Basel). 2024;16:1532.
PubMed
Abstract available
Molecular profiling of a bladder cancer with very high tumour mutational burden.
Cell Death Discov. 2024;10:202.
PubMed
Abstract available
Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict
Neoadjuvant Therapy Efficacy in Bladder Cancer.
Clin Genitourin Cancer. 2024;22:102087.
PubMed
Abstract available
C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial
carcinoma: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2024;197:104352.
PubMed
Abstract available
Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma.
Curr Oncol Rep. 2024;26:496-503.
PubMed
Abstract available
Identification of a pyroptosis-immune-related lncRNA signature for prognostic and
immune landscape prediction in bladder cancer patients.
Discov Oncol. 2024;15:140.
PubMed
Abstract available
Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms
and biological pathways in bladder cancer.
Eur J Med Res. 2024;29:257.
PubMed
Abstract available
Pan fibroblast growth factor receptor inhibitor associated retinopathy.
Eur J Ophthalmol. 2023 Dec 12:11206721231220334. doi: 10.1177/11206721231220334.
PubMed
Abstract available
Re: Steven Monda, Manolis Pratsinis, Hansen Lui, et al. Secondary Bladder Cancer
After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and
Surgery. Eur Urol Focus. In press. http://doi.org/10.1016/j.euf.2023.09.002.
Eur Urol Focus. 2024 Apr 25:S2405-4569(24)00061.
PubMed
Whole transcriptome sequencing identifies a competitive endogenous RNA network
that regulates the immunity of bladder cancer.
Heliyon. 2024;10:e29344.
PubMed
Abstract available
Change in Tissue Microbiome and Related Human Beta Defensin Levels Induced by
Antibiotic Use in Bladder Carcinoma.
Int J Mol Sci. 2024;25:4562.
PubMed
Abstract available
Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.
Int J Nanomedicine. 2024;19:3677-3695.
PubMed
Abstract available
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for
high-risk non-muscle invasive bladder cancer improves intravesical
recurrence-free survival (BRIGHT study).
Int J Urol. 2024 May 2. doi: 10.1111/iju.15483.
PubMed
Abstract available
Differences in oncological benefits from second transurethral resection between
white-light initial surgery and photodynamic diagnosis-guided initial surgery for
primary high-risk non-muscle invasive bladder cancer.
Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15474.
PubMed
Abstract available
Independent validation of genetic risk model to progression after intravesical
bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer.
Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15484.
PubMed
Performance of (18)F-FDG PET/MRI and its parameters in staging and neoadjuvant
therapy response evaluation in bladder cancer.
iScience. 2024;27:109657.
PubMed
Abstract available
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization
analysis.
J Autoimmun. 2024;146:103231.
PubMed
Abstract available
New synergistic combination therapy approaches with HDAC inhibitor quisinostat,
cisplatin or PARP inhibitor talazoparib for urothelial carcinoma.
J Cell Mol Med. 2024;28:e18342.
PubMed
Abstract available
Reply for Comment on: Vitamin C and catheter-related bladder discomfort after
transurethral resection of bladder tumor.
J Clin Anesth. 2024;95:111445.
PubMed
Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer
in Clinical Practice-A Comprehensive Review on State-of-the-Art Advances and
Critical Issues.
J Clin Med. 2024;13:2182.
PubMed
Abstract available
A Novel Decision Tree Model for Predicting the Cancer-Specific Survival of
Patients with Bladder Cancer Treated with Radical Cystectomy.
J Clin Med. 2024;13:2177.
PubMed
Abstract available
Postoperative Outcomes and Analgesic Requirements of Single-Port vs Multiport
Robotic-Assisted Radical Cystectomy.
J Endourol. 2024;38:438-443.
PubMed
Abstract available
A Streamlined PENK Methylation Test in Urine DNA, EarlyTect BCD, Effectively
Detects Bladder Cancer in Patients with Hematuria.
J Mol Diagn. 2024 Apr 25:S1525-1578(24)00084.
PubMed
Abstract available
Grade Heterogeneity in High-Grade Urothelial Carcinomas: Does It Have an Impact
on the Survival of Patients With Intermediate/High-Risk Nonmuscle-Invasive
Bladder Cancer Who Received Adequate Adjuvant Bacillus Calmette-Guerin Therapy?
J Urol. 2024 May 1:101097JU0000000000003990. doi: 10.1097/JU.0000000000003990.
PubMed
Abstract available
Therapy Attrition and Lessons for Future Approaches to Treatment of Advanced
Urothelial Cancer.
JAMA Netw Open. 2024;7:e249426.
PubMed
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial
Carcinoma in the US.
JAMA Netw Open. 2024;7:e249417.
PubMed
Abstract available
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive
Bladder Cancer.
JCO Precis Oncol. 2024;8:e2300274.
PubMed
Abstract available
Novel artesunate-metformin conjugate inhibits bladder cancer cell growth
associated with Clusterin/SREBP1/FASN signaling pathway.
Korean J Physiol Pharmacol. 2024;28:219-227.
PubMed
Abstract available
Erdafitinib (Balversa) for urothelial carcinoma.
Med Lett Drugs Ther. 2024;66:e83-e84.
PubMed
Genomic Profiling and Molecular Characterisation of Metastatic Urothelial
Carcinoma.
Medicina (Kaunas). 2024;60:585.
PubMed
Abstract available
Identification of cuproptosis-related long non-coding RNA and construction of a
novel prognostic signature for bladder cancer: An observational study.
Medicine (Baltimore). 2024;103:e38005.
PubMed
Abstract available
Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in
Urothelial Carcinoma.
Molecules. 2024;29:1896.
PubMed
Abstract available
Universal nanocomposite coating with antifouling and redox capabilities for
electrochemical affinity biosensing in complex biological fluids.
Nanoscale Horiz. 2024;9:843-852.
PubMed
Abstract available
First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer.
Nat Rev Drug Discov. 2024 Apr 26. doi: 10.1038/d41573-024-00073.
PubMed
Comparing survival in trial- versus routine-care advanced urothelial cancer
patients on immune checkpoint blockade.
Pharmacoepidemiol Drug Saf. 2024;33:e5798.
PubMed
Abstract available
Urothelial Carcinoma: Epidemiology and Imaging-Based Review.
R I Med J (2013). 2024;107:26-32.
PubMed
Abstract available
A novel model of artificial intelligence based automated image analysis of CT
urography to identify bladder cancer in patients investigated for macroscopic
hematuria.
Scand J Urol. 2024;59:90-97.
PubMed
Abstract available
Cystectomy for bladder cancer in Sweden - short-term outcomes after
centralization.
Scand J Urol. 2024;59:84-89.
PubMed
Abstract available
A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity
in bladder cancer by regulating RUVBL2.
Transl Oncol. 2024;45:101962.
PubMed
Abstract available
Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer.
Trends Mol Med. 2024 Apr 30:S1471-4914(24)00092.
PubMed
Abstract available
Pathologic and survival outcomes following radical cystectomy for "progressive"
and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by
neoadjuvant chemotherapy status.
Urol Oncol. 2024 May 1:S1078-1439(24)00438-1. doi: 10.1016/j.urolonc.2024.
PubMed
Abstract available
Incidence and management of prostatic urethra recurrence in a cohort of 21
patients who received BCG induction for non-muscle invasive bladder cancer.
Urol Oncol. 2024 Apr 29:S1078-1439(24)00436.
PubMed
Abstract available
Real-world use, dose intensity, and adherence to enfortumab vedotin in locally
advanced or metastatic urothelial cancer.
Urol Oncol. 2024;42:177.
PubMed
Abstract available
Efficacy of conduction hyperthermia in the treatment of non-muscle invasive
bladder cancer: A systematic review.
Urol Oncol. 2024 Apr 25:S1078-1439(24)00399.
PubMed
Abstract available
Neoadjuvant cisplatin-based chemotherapy in nonmetastatic muscle-invasive bladder
cancer: A systematic review and pooled meta-analysis to determine the preferred
regimen.
Urology. 2024 Apr 27:S0090-4295(24)00306-6. doi: 10.1016/j.urology.2024.
PubMed
Abstract available
Scoring PD-L1 Expression in Urothelial Carcinoma: An International
Multi-Institutional Study on Comparison of Manual and Artificial Intelligence
Measurement Model (AIM-PD-L1) Pathology Assessments.
Virchows Arch. 2024;484:597-608.
PubMed
Abstract available
Understanding the role of transmembrane 9 superfamily member 1 in bladder cancer
pathogenesis.
World J Clin Oncol. 2024;15:468-471.
PubMed
Abstract available
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the
implementation of the EAU guidelines recommendations for collecting and reporting
complications at a high-volume referral center.
World J Urol. 2024;42:270.
PubMed
Abstract available
A balanced perspective on bladder preservation and systemic treatment in
muscle-invasive bladder cancer.
World J Urol. 2024;42:288.
PubMed
[Practical application of the Paris system for reporting urinary cytology].
Zhonghua Bing Li Xue Za Zhi. 2024;53:470-476.
PubMed
Abstract available
Thank you for your interest in scientific medicine.